Literature DB >> 15122916

Characterization of bis(levuglandinyl) urea derivatives as products of the reaction between prostaglandin H2 and arginine.

Irene Zagol-Ikapitte1, Nathalie Bernoud-Hubac, Venkataraman Amarnath, L Jackson Roberts, Olivier Boutaud, John A Oates.   

Abstract

Levuglandins are gamma-keto aldehydes formed by rearrangement of prostaglandin (PG) H(2) in aqueous solution. Levuglandins are highly reactive with primary amines. We had previously characterized adducts formed after reaction of levuglandin E(2) (LGE(2)) or PGH(2) with lysine. In this study, we assessed whether reaction of PGH(2) with arginine yielded covalent adducts. Using N(alpha)-acetylarginine and both PGH(2) and synthetic LGE(2), we discovered a novel series of levuglandinyl adducts derived from reaction of two levuglandin moieties with the guanidino group of arginine. Subsequent spontaneous hydrolysis of the adducted amino acid yields bis(levuglandinyl) urea and the corresponding ornithine residue. Using liquid chromatography tandem mass spectrometry, we characterized the molecular structure of these novel adducts and demonstrated their formation after coincubation of PGH(2) with synthetic peptides and proteins. The soluble characteristic of these molecules provides a potential strategy for development of biological markers of lipid modification of proteins following cyclooxygenase activity or lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122916     DOI: 10.1021/bi049842r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studies.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Satyawan Jadhav; John A Oates; Olivier Boutaud
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-21       Impact factor: 3.205

Review 2.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

3.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

4.  Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.

Authors:  Erica J Carrier; Venkataraman Amarnath; John A Oates; Olivier Boutaud
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

5.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14

6.  Characterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Manju Bala; L Jackson Roberts; John A Oates; Olivier Boutaud
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

Review 7.  Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.

Authors:  Sean S Davies; Linda S May-Zhang; Olivier Boutaud; Venkataraman Amarnath; Annet Kirabo; David G Harrison
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.